Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FMEG4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,899
Award facts
- Contract value 100% obligated
- $21,899.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,899.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This delivery order, issued on January 28, 2026, with an ultimate completion date of February 19, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement competition. The order will be fulfilled at the contractor's Park Ridge facility and represents a discrete purchase under DMS Pharmaceutical Group's existing pharmaceutical supply relationship with the federal government.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to supply specialized pharmaceutical requirements for federal military medical operations, positioning it as a critical regional pharmaceutical supplier within the DoD medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMEG4?
SPE2DR26FMEG4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FMEG4 worth?
The government has obligated $21,899 on SPE2DR26FMEG4.
Is contract SPE2DR26FMEG4 an order under another contract?
Yes. SPE2DR26FMEG4 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEG4 competed?
The extent of competition for SPE2DR26FMEG4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award